Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in <i>TP53</i> mutant head and neck squamous cell carcinoma (HNSCC)-Reference-Cited by-同舟云学术

Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)

Published:2023-02-02 Issue:1 Volume:14 Page:85-95
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Alam Md Maksudul¹,Fermin Janmaris Marin¹,Knackstedt Mark¹,Noonan Mackenzie J.¹,Powell Taylor²,Goodreau Landon²,Daniel Emily K.¹,Rong Xiaohua¹,Moore-Medlin Tara¹³,Khandelwal Alok R.¹³,Nathan Cherie-Ann O.¹³

Affiliation:

1. Department of Otolaryngology-Head and Neck Surgery, LSU-Health Sciences Center, Shreveport, LA 71103, USA

2. School of Medicine, LSU-Health Sciences Center, Shreveport, LA 71103, USA

3. Feist-Weiller Cancer Center, LSU-Health Sciences Center, Shreveport, LA 71103, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference46 articles.

1. Head and neck cancer;Ferris;Lancet,2008

2. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial;Gillison;J Natl Cancer Inst,2008

3. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1;Jasser;Science,2011